Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States

View ORCID ProfileJessica T. Davis, View ORCID ProfileMatteo Chinazzi, View ORCID ProfileNicola Perra, Kunpeng Mu, View ORCID ProfileAna Pastore y Piontti, View ORCID ProfileMarco Ajelli, View ORCID ProfileNatalie E. Dean, Corrado Gioannini, View ORCID ProfileMaria Litvinova, View ORCID ProfileStefano Merler, Luca Rossi, Kaiyuan Sun, Xinyue Xiong, View ORCID ProfileM. Elizabeth Halloran, View ORCID ProfileIra M. Longini Jr., Cécile Viboud, View ORCID ProfileAlessandro Vespignani
doi: https://doi.org/10.1101/2021.03.24.21254199
Jessica T. Davis
aLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jessica T. Davis
Matteo Chinazzi
aLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matteo Chinazzi
Nicola Perra
bNetworks and Urban Systems Centre, University of Greenwich, London, UK
aLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicola Perra
Kunpeng Mu
aLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Pastore y Piontti
aLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ana Pastore y Piontti
Marco Ajelli
cDepartment of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA
aLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marco Ajelli
Natalie E. Dean
dDepartment of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natalie E. Dean
Corrado Gioannini
eISI Foundation, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Litvinova
cDepartment of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, IN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Litvinova
Stefano Merler
fBruno Kessler Foundation, Trento Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stefano Merler
Luca Rossi
eISI Foundation, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaiyuan Sun
gDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinyue Xiong
aLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Elizabeth Halloran
hFred Hutchinson Cancer Research Center, Seattle, WA, USA
iDepartment of Biostatistics, University of Washington, Seattle, WA. USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for M. Elizabeth Halloran
Ira M. Longini Jr.
dDepartment of Biostatistics, College of Public Health and Health Professions, University of Florida, Gainesville, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ira M. Longini Jr.
Cécile Viboud
gDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandro Vespignani
aLaboratory for the Modeling of Biological and Socio-technical Systems, Northeastern University, Boston, MA USA
eISI Foundation, Turin, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alessandro Vespignani
  • For correspondence: a.vespignani@northeastern.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Given the narrowness of the initial testing criteria, the SARS-CoV-2 virus spread through cryptic transmission in January and February, setting the stage for the epidemic wave experienced in March and April, 2020. We use a global metapopulation epidemic model to provide a mechanistic understanding of the global dynamic underlying the establishment of the COVID-19 pandemic in Europe and the United States (US). The model is calibrated on international case introductions at the early stage of the pandemic. We find that widespread community transmission of SARS-CoV-2 was likely in several areas of Europe and the US by January 2020, and estimate that by early March, only 1 − 3 in 100 SARS-CoV-2 infections were detected by surveillance systems. Modeling results indicate international travel as the key driver of the introduction of SARS-CoV-2 with possible importation and transmission events as early as December, 2019. We characterize the resulting heterogeneous spatio-temporal spread of SARS-CoV-2 and the burden of the first COVID-19 wave (February-July 2020). We estimate infection attack rates ranging from 0.78%-15.2% in the US and 0.19%-13.2% in Europe. The spatial modeling of SARS-CoV-2 introductions and spreading provides insights into the design of innovative, model-driven surveillance systems and preparedness plans that have a broader initial capacity and indication for testing.

Competing Interest Statement

M.E.H. reports grants from National Institute of General Medical Sciences, during the conduct of the study; M.A. reports research funding from Seqirus, not related to COVID-19. A.V., M.C. and A.P.P. report grants from Metabiota inc., outside the submitted work. No other relationships or activities that could appear to have influenced the submitted work.

Funding Statement

A.V., M.E.H., N.E.D., and I.M.L acknowledge support from NIH-R56AI148284 award. S.M. acknowledges support from the EU H2020 MOOD project. C.G. and L.R. acknowledge support from the EU H2020 Icarus project. M.A., M.C.and A.V. acknowledge support from COVID Supplement CDC-HHS-6U01IP001137-01. M.C. and A.V. acknowledge support from Google Cloud and Google Cloud Research Credits program to fund this project. A.V. acknowledges support from the McGovern and the Chleck Foundation. The findings and conclusions in this study are those of the authors and do not necessarily represent the official position of the funding agencies, the National Institutes of Health, or the U.S. Department of Health and Human Services.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Proprietary airline data are commercially available from Official Aviation Guide (OAG) and IATA databases. The GLEAM model is publicly available at http://www.gleamviz.org/.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 26, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States
Jessica T. Davis, Matteo Chinazzi, Nicola Perra, Kunpeng Mu, Ana Pastore y Piontti, Marco Ajelli, Natalie E. Dean, Corrado Gioannini, Maria Litvinova, Stefano Merler, Luca Rossi, Kaiyuan Sun, Xinyue Xiong, M. Elizabeth Halloran, Ira M. Longini Jr., Cécile Viboud, Alessandro Vespignani
medRxiv 2021.03.24.21254199; doi: https://doi.org/10.1101/2021.03.24.21254199
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States
Jessica T. Davis, Matteo Chinazzi, Nicola Perra, Kunpeng Mu, Ana Pastore y Piontti, Marco Ajelli, Natalie E. Dean, Corrado Gioannini, Maria Litvinova, Stefano Merler, Luca Rossi, Kaiyuan Sun, Xinyue Xiong, M. Elizabeth Halloran, Ira M. Longini Jr., Cécile Viboud, Alessandro Vespignani
medRxiv 2021.03.24.21254199; doi: https://doi.org/10.1101/2021.03.24.21254199

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1097)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9773)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2313)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1562)
  • Health Policy (736)
  • Health Systems and Quality Improvement (604)
  • Hematology (238)
  • HIV/AIDS (504)
  • Infectious Diseases (except HIV/AIDS) (11650)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (238)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2144)
  • Nursing (134)
  • Nutrition (337)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1180)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2182)
  • Public and Global Health (4663)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)